Clinical Trial Update: Treatment of Refractory Chronic Cough With PA101 [Phase 2]

View source ↗

Summary

Phase 2 study of PA101 for refractory chronic cough has completed. The snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• PA101

Snippet

Sponsor: Patara Pharma | Conditions: Refractory Chronic Cough | Phase 2 | Status: COMPLETED